Sk Life Science, Inc.
Clinical trials sponsored by Sk Life Science, Inc., explained in plain language.
-
New study tests solo drug for controlling epileptic seizures
Disease control OngoingThis study is testing whether the drug cenobamate can effectively control seizures when used alone in adults with focal epilepsy. It will enroll about 49 people who are either newly diagnosed or have had seizures return. Participants will take the drug for up to a year to see if …
Phase: PHASE4 • Sponsor: SK Life Science, Inc. • Aim: Disease control
Last updated Apr 04, 2026 07:51 UTC
-
Year-Long safety check for promising seizure drug
Disease control ENROLLING_BY_INVITATIONThis study aims to check the long-term safety of the seizure medication cenobamate over one year. It is for 145 people with generalized tonic-clonic seizures who finished a previous core study. Participants will take cenobamate daily, with doses adjusted as needed, while doctors …
Phase: PHASE3 • Sponsor: SK Life Science, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC